Practice Areas - Equity Capital Markets Law Firms and Lawyers
| Deal Date: | 31-10-2016 | Practice Area: | Equity Capital Markets |
| Deal Title: | China Resources Pharmaceutical Group HKSE IPO | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Clifford Chance advised China Resources Pharmaceutical Group on its USD1.8 billion IPO and listing on the Hong Kong Stock Exchange. CR Pharma is a leading integrated pharmaceutical company in China engaged in the research and development, manufacturing, distribution and retail of an extensive range of pharmaceutical and other healthcare products. The joint sponsors on the deal were CCBI, CICC, Goldman Sachs and Merrill Lynch.
|
||
| Financial Center: | Hong Kong | Value: | 1000.01-5000.00 |
| Advised Party: | Issuer | Law Firm | Clifford Chance |
| Issuer Jurisdiction- | China | Listing Jurisdiction- | Hong Kong |
| Classification: |
Initial Public Offerings Hong Kong Stock Exchange |
Lawyer | Amy Lo |
